Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report
Omar Najjar,
Aaron Varghese,
Maryam Shahi,
Russell Vang,
Stephanie Gaillard,
Thomas Smith,
Amanda N. Fader
Affiliations
Omar Najjar
The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD 21205, United States
Aaron Varghese
The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD 21205, United States
Maryam Shahi
Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21205, United States
Russell Vang
Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21205, United States
Stephanie Gaillard
The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD 21205, United States; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD 21205, United States
Thomas Smith
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD 21205, United States
Amanda N. Fader
The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD 21205, United States; Corresponding author at: 600 N. Wolfe St., Phipps Bldg., Rm 281, Baltimore, MD 21287, United States.
